Surface-engineered extracellular vesicles to modulate antigen-specific T cell expansion for cancer immunotherapy
X. Lyu, T. Yamano, S. Imai, T. V. Le, D. Bolidong, M. Ueda, S. Warashina, H. Mukai, S. Hayashi, K. Matoba, T. Nishino, R. Hanayama
The paper develops antigen-presenting extracellular vesicles (AP-EVs) engineered to enhance T cell expansion and anticancer immunity through combined immunotherapy.
bioRxiv · Sep 25, 2023 · PreprintBioengineering